A detailed history of Fny Investment Advisers, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 20,000 shares of CTLT stock, worth $1.2 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
20,000
Previous 37 53954.05%
Holding current value
$1.2 Million
Previous $2,000 60450.0%
% of portfolio
0.58%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$56.16 - $60.96 $1.12 Million - $1.22 Million
20,000 New
20,000 $1.21 Million
Q1 2023

Apr 12, 2023

BUY
$45.44 - $74.26 $23,856 - $38,986
525 New
525 $34,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.8B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.